However, others reported the association between CB1/CB2 upregulation and longer survival time in hepatocellular carcinoma (Xu et al., 2006) and non-small cell lung cancer (Preet et al., 2011; McAllister et al., 2021). This evidence concerns the gene CNR2 and hepatocellular carcinoma.